TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Anne-Marie Bleau
Clinical Operations Manager at Sylentis

Profile

Anne-Marie Bleau is Clinical Operations Manager at Sylentis since 2016 where she oversees the clinical development of new ophthalmic siRNA candidates. Earlier to Sylentis, she joined the Ophthalmology Department at the Clínica Universidad de Navarra (Pamplona) as Clinical Investigator and study coordinator.

She holds a Ph.D. in Pharmacology from the University of Montreal (2002). She then undertook two post-doctoral trainings at the University Paris 7 and the Memorial Sloan-Kettering Cancer Center (New York) in cancer research. She worked as a collaborative investigator at the Centro de Investigación Médica Aplicada (Pamplona), which was supported by a Marie Curie International Fellowship.

Anne-Marie Bleau's Network

Agenda Sessions

  • Clinical Development of Tivanisiran, A siRNA for the Treatment of Dry Eye Disease

    , 13:45
  • Clinical Development of Tivanisiran, A siRNA for the Treatment of Dry Eye Disease

    , 13:45